Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 356

1.

[The participation of the dopaminergic system of the striatum in the regulation of catalepsy in mice and rats of different genotypes].

Skrinskaia IuA, Popova NK, Nikulina EM, Kulikov AV.

Zh Vyssh Nerv Deiat Im I P Pavlova. 1997 Nov-Dec;47(6):1032-9. Russian.

PMID:
9472169
2.

Genotypic influences on striatal dopaminergic regulation in mice.

Severson JA, Randall PK, Finch CE.

Brain Res. 1981 Apr 6;210(1-2):201-15.

PMID:
6261873
3.

Dopamine characteristics in different rat genotypes: the relation to absence epilepsy.

de Bruin NM, van Luijtelaar EL, Jansen SJ, Cools AR, Ellenbroek BA.

Neurosci Res. 2000 Oct;38(2):165-73.

PMID:
11000443
4.

Dopaminergic mediation of beta-endorphin-induced catalepsy.

Van Loon GR, Kim C.

Res Commun Chem Pathol Pharmacol. 1978 Jul;21(1):37-44.

PMID:
567367
5.

[Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].

Zharkovskiń≠ AM, Nurk AM.

Fiziol Zh SSSR Im I M Sechenova. 1981 Nov;67(11):1606-10. Russian.

PMID:
6799331
6.

Effects of dextromethorphan on dopamine dependent behaviours in rats.

Gaikwad RV, Gaonkar RK, Jadhav SA, Thorat VM, Jadhav JH, Balsara JJ.

Indian J Exp Biol. 2007 Aug;45(8):712-9.

PMID:
17877148
7.

On the role of brain serotonin in expression of genetic predisposition to catalepsy in animal models.

Popova NK, Kulikov AV.

Am J Med Genet. 1995 Jun 19;60(3):214-20.

PMID:
7573174
8.
9.

[Changes in the serotonin system of the brains of rats genetically predisposed to catalepsy].

Popova NK, Kulikov AV, Kolpakov VG, Barykina NN, Alekhina TA.

Zh Vyssh Nerv Deiat Im I P Pavlova. 1985 Jul-Aug;35(4):742-6. Russian.

PMID:
2413649
10.

Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo.

Kaneko M, Sato K, Horikoshi R, Yaginuma M, Yaginuma N, Shiragata M, Kumashiro H.

Prostaglandins Leukot Essent Fatty Acids. 1992 May;46(1):53-7.

PMID:
1378633
11.

Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.

Geurts M, Hermans E, Maloteaux JM.

Eur J Pharmacol. 1999 Oct 8;382(2):119-27.

PMID:
10528146
12.

Behavioral and biochemical changes after bilateral electrolytic lesions of the red nucleus of rat.

Kolasa K, Consolo S, Costi P, Kleinrok Z, Zecca L.

Pharmacol Biochem Behav. 1995 May;51(1):29-35.

PMID:
7617729
13.

The enhancement of the hypomotility induced by small doses of haloperidol in the phase of dopaminergic supersensitivity in mice.

Masuda Y, Murai S, Saito H, Abe E, Fujiwara H, Kohori I, Itoh T.

Neuropharmacology. 1991 Jan;30(1):35-40.

PMID:
2046878
14.
15.

5-HT2A serotonin receptors in the brain of rats and mice hereditarily predisposed to catalepsy.

Kulikov AV, Avgustinovich DF, Kolpakov VG, Maslova GB, Popova NK.

Pharmacol Biochem Behav. 1995 Mar;50(3):383-7.

PMID:
7617676
16.

[The role of the genotype in the cataleptogenic effect of neuroleptics].

Skrinskaia IuA, Nikulina EM, Popova NK.

Eksp Klin Farmakol. 1992 Nov-Dec;55(6):7-9. Russian.

PMID:
1363957
18.
19.

Effects of Ca2+ antagonists on motor activity and the dopaminergic system in aged mice.

Kurosaki R, Akasaka M, Michimata M, Matsubara M, Imai Y, Araki T.

Neurobiol Aging. 2003 Mar-Apr;24(2):315-9.

PMID:
12498965
20.

[Characteristics of the brain dopamine system in mice carrying the quaking neurological mutation].

Nikulina IuA, Skrinskaia IuA, Popova NK.

Biull Eksp Biol Med. 1988 Aug;106(8):212-4. Russian.

PMID:
3262000

Supplemental Content

Support Center